Stocks · News reference
Oncology Institute (NASDAQ:TOI) raises FY2026 sales outlook from $630.000 million-$650.000 million to $650.000 million-$670.000 million vs $651.941 million estimate.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Oncology Institute (NASDAQ:TOI) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. This transcript is brought to you by Benzinga APIs. For real-time
The Oncology Institute (NASDAQ:TOI) reported quarterly losses of $(0.08) per share which missed the analyst consensus estimate of $(0.06) by 33.33 percent. This is a 46.67 percent increase over losses of $(0.15) per